Kristina Keller
YOU?
Author Swipe
View article: The neuro-ocular costs of texting during driving
The neuro-ocular costs of texting during driving Open
Texting while driving is among the most dangerous forms of distraction, yet the neurophysiological mechanisms linking cognitive load, gaze control, and driving behavior remain poorly understood. Here, EEG, eye tracking, head kinematics, an…
View article: National Consensus on the Assessment of Visual Function for Driving in Switzerland
National Consensus on the Assessment of Visual Function for Driving in Switzerland Open
Purpose To establish a national consensus on assessing visual function for fitness to drive in Switzerland. Methods The minimum medical requirements for visual function for fitness to drive are regulated by Swiss Federal Law, namely, by th…
View article: Metabolomics-based Sleepiness Markers for Risk Prevention and Traffic Safety (ME-SMART): a monocentric, controlled, randomized, crossover trial
Metabolomics-based Sleepiness Markers for Risk Prevention and Traffic Safety (ME-SMART): a monocentric, controlled, randomized, crossover trial Open
Background Too little sleep and the consequences thereof are a heavy burden in modern societies. In contrast to alcohol or illicit drug use, there are no quick roadside or workplace tests for objective biomarkers for sleepiness. We hypothe…
View article: Sleep and the Fitness to Drive: A Swiss Perspective
Sleep and the Fitness to Drive: A Swiss Perspective Open
Medical conditions and behavioral patterns affecting sleep are a largely underestimated threat to traffic safety. Unsupervised or even illegal self-treatment of sleep issues by, for example, anti-histamines, cannabis products, or stimulant…
View article: Fitness-to-drive for glioblastoma patients
Fitness-to-drive for glioblastoma patients Open
OBJECTIVE The management of brain tumour patients who would like to resume driving is complex, and needs multidisciplinary input and a consensus among treating physicians. The Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society f…
View article: Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM)
Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM) Open
OBJECTIVE The management of brain tumour patients who would like to resume driving is complex, and needs multidisciplinary input and a consensus among treating physicians. The Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society f…
View article: Buckle up!
Buckle up! Open
View article: Reviewing a decade of changes in Swiss traffic medicine – repercussions/ramifications on future challenges
Reviewing a decade of changes in Swiss traffic medicine – repercussions/ramifications on future challenges Open
Traffic Medicine is one of the Swiss legal entities that contribute to minimizing traffic casualties. But has pertaining Swiss legislation adequately incorporated developments in medicine, science, society and politics to attain this goal?…
View article: Fahreignung von Tumorpatienten – was ist zu beachten?
Fahreignung von Tumorpatienten – was ist zu beachten? Open
In der Schweiz liegt die Inzidenz von Krebspatienten bei 40 000 pro Jahr (1). Im Zusammenhang mit einer Krebserkrankung stellt sich häufig die Frage, ob die betroffene Person ein Fahrzeug sicher lenken kann. Im vorliegenden Artikel werden …
View article: Compositie analyse van de Limburgse economie
Compositie analyse van de Limburgse economie Open
Op verzoek van de Provincie Limburg hebben het Centraal Bureau voor de Statistiek (CBS) en TNO een compositie-analyse uitgevoerd van de Limburgse economie. Er wordt een integraal beeld geschetst van de economische ontwikkeling, de regional…
View article: Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo
Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo Open
We have previously described novel histone acetyltransferase (HAT) inhibitors that block neuroblastoma cell growth in vitro . Here we show that two selected pyridoisothiazolone HAT inhibitors, PU139 and PU141, induce cellular histone hypoa…